Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (161-170 of 315) with videos related to

Pageof 32
Sort By:
The Lancet. Haematology|July 23, 2017
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysisThomas Luft, Axel Benner, Sonata Jodele, et al.
Blood|December 3, 2011
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationYun Chen, Brian Kornblit, Donald K Hamlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control studyChristian Junghanss, Kieren A Marr, Rachel A Carter, et al.
Transplantation|November 20, 2002
Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantationGuido Kobbe, Ulrich Germing, Manuel Aivado, et al.
Bone Marrow Transplantation|February 27, 2019
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remissionColin D Godwin, Jonathan R Fromm, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromesBart L Scott, J Y Park, H Joachim Deeg, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Veterinary and Comparative Oncology|July 5, 2022
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high-grade B-cell lymphomaAlexandra Gareau, Toko Sekiguchi, Emma Warry, et al.
British Journal of Haematology|August 22, 2003
Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemiaPhilippe Guardiola, Peter Kurre, Amalia Vlad, et al.
Blood|April 18, 2019
Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantationK Scott Baker, Wendy M Leisenring, Pamela J Goodman, et al.
Pageof 32

Showing results (161-170 of 315) with videos related to

Sort By:
Pageof 32
The Lancet. Haematology|July 23, 2017
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysisThomas Luft, Axel Benner, Sonata Jodele, et al.
Blood|December 3, 2011
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationYun Chen, Brian Kornblit, Donald K Hamlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control studyChristian Junghanss, Kieren A Marr, Rachel A Carter, et al.
Transplantation|November 20, 2002
Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantationGuido Kobbe, Ulrich Germing, Manuel Aivado, et al.
Bone Marrow Transplantation|February 27, 2019
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remissionColin D Godwin, Jonathan R Fromm, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromesBart L Scott, J Y Park, H Joachim Deeg, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Veterinary and Comparative Oncology|July 5, 2022
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high-grade B-cell lymphomaAlexandra Gareau, Toko Sekiguchi, Emma Warry, et al.
British Journal of Haematology|August 22, 2003
Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemiaPhilippe Guardiola, Peter Kurre, Amalia Vlad, et al.
Blood|April 18, 2019
Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantationK Scott Baker, Wendy M Leisenring, Pamela J Goodman, et al.
Pageof 32